StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by atomicnumber31on Oct 10, 2019 2:26pm

302 Views

Post# 30218415

RE:RE:QUOTE TELLS IT ALL!!!!

LithLover wrote: A mid day halt on a Thursday. Let's see what happens when this gets out tonight and SZLS is on the high volume and % increase for gainers on the tsx. A $20M market cap is just ridiculous when you consider the potential markets and other partnerships lined up. Won't take many more of these to have a $100M or higher market cap for a 5x SP increase. Let's hope they have a steady stream of announcements. BTW sure like that it was halted first, that beats reading about facebook likes LOL Had to get that in there.

Will be interesting over the next session or two as this peroclates through Euro medical community and news centers

Bullboard Posts

Eminent acquires promising Nevada gold project